Ted W. Love, M.D. Sickle Cell, Global Blood Therapeutics

Austin Tang — Wed, 19 Feb 2020 17:57:37 +0000

http://goodnewsplanet.com/wp-content/uploads/2020/02/dr_ted_love_1.mp3
Black History Month is when we Focus on Trailblazers in the African American Community.
That includes medical pioneers who’ve made an impact on conditions like sickle cell disease… Agenetic Blood Disorder that Disproportionately Affects the Black Community. Although the Disease was discovered 100 years ago, it has historically lacked treatment options.
Change has come. Dr. Ted Love discusses the latest advances in managing this devastating disease, he is also the president and CEO of Global Blood Therapeutics, a Biotech Company based in San Francisco.
www.sicklecellspeaks.com
www.Oxbryta.com
Ted W. Love, M.D.
President and Chief Executive Officer, GBT
Dr. Love joined GBT in June 2014 as president and chief executive officer with broad leadership and management experience in the biotech/pharmaceutical industry. Before that, he was executive vice president, research and development and technical operations at Onyx Pharmaceuticals, Inc., where he played an instrumental role in initiating and completing several of Onyx’s first Phase 3 clinical trials. Prior to Onyx, Dr. Love served as president, chief executive officer and chairman of Nuvelo, Inc., where he led growth of the company to a market capitalization of $1 billion. Prior to that, he served as senior vice president, development at Theravance, Inc. Earlier in his career, Dr. Love held a number of senior management positions in medical affairs and product development at Genentech, where he served as chairman of Genentech’s Product Development Committee. As vice president, product development, Dr. Love oversaw the development strategy and execution leading to approvals of Rituxan®, Herceptin®, Xolair®, TNKase®, Raptiva and Avastin®. Dr. Love has served as a consultant in medicine in the Department of Cardiology at the Massachusetts General Hospital. He currently serves on the board of directors of Amicus Therapeutics, Inc., Portola Pharmaceuticals, Inc. and the Biotechnology Innovation Organization (BIO). Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School. He completed a residency in internal medicine and a fellowship in cardiology at the Massachusetts General Hospital. Originally from Huntsville, AL, Dr. Love resides in San Francisco, CA.
https://www.cdc.gov/ncbddd/sicklecell/data.html
#ted #love #sickle #cell #disease #president #global #blood #therapeutic #therapeutics #black #history #month #trailblazers #african #american #community #agenetic #disorder #treatment #san #francisco #oxbryta #speaks #sicklecellspeaks

The post Ted W. Love, M.D. Sickle Cell, Global Blood Therapeutics appeared first on Good News!.

September is National Sickle Cell Awareness Month

admin — Tue, 24 Sep 2019 20:39:25 +0000

http://goodnewsplanet.com/wp-content/uploads/2019/09/sickle_cell_1.mp3
https://www.sicklecelldisease.org/get-involved/events/national-sickle-cell-awareness-month/
Sickle Cell Speaks: Dispelling Misconceptions and Breaking Down Stigmas Associated with Sickle Cell Disease

Have you ever heard that sickle cell disease (SCD) is contagious or people with sickle cell are lazy?

Believe it or not, these are just two of many common misconceptions people with SCD have to confront, leaving people with this genetic blood disorder feeling misunderstood and often isolated.

Cultural barriers and misinformation about SCD have contributed to its misunderstood reputation, and it is more important than ever to educate people in the U.S. about the disease so we can reduce the ignorance surrounding it. Storytelling is among the best ways to bring awareness to the disease and help squash associated misconceptions and stigmas.

The SCD experience is highly varied. By highlighting personal stories of individuals with the disease, it can help to bring about a better understanding of the challenges people face. Historically, SCD has been affected by issues of healthcare inequality, including challenges in access to care and limited funding support.

Sickle Cell Speaks is a new campaign that aims to raise awareness and understanding of sickle cell by highlighting the personal stories of individuals and families impacted.

SCD is a group of inherited red blood cell disorders which affect approximately 100,000 people in the U.S., with people of African descent making up 90% (1 in 365 births). The most talked about symptom is often severe pain episodes or crises, but one of the most serious consequences of SCD is hemolytic anemia, or the destruction of red blood cells. The damaged blood vessels reduce blood flow to organs in the body, and this reduced blood flow permanently injures key organs and puts patients at a greater risk of stroke and early death.

National Sickle Cell Awareness Month, your audience can meet Mapillar Dahn, a mom caring for three children who have SCD. She’ll be joined by Beverley Francis-Gibson, the President & CEO of Sickle Cell Disease Association of America. Both guests can discuss the new campaign, the stigmas patients face and long-term impacts of the disease.

The post September is National Sickle Cell Awareness Month appeared first on Good News!.

sickle Archives - Good News!

Ted W. Love, M.D. Sickle Cell, Global Blood Therapeutics

September is National Sickle Cell Awareness Month